UNSPSC 41141948: Creatine test system

In this classification, Creatine test system connotes a device used to measure Creatine levels. US FDA regulates Creatine test system under 21 CFR 862.1210 and under FDA product code JLA.

UNSPSC 41141948 Creatine test system (Commodity) encompasses forensic and clinical laboratory diagnostic testing kits and reagents—including immunoassay reagents for substance analysis, DNA screening kits, and certified reference materials (drug standards)—that state and local forensic, public health, and law enforcement laboratories procure for analytical method validation and evidentiary sample analysis. The scope of work actual state and local buyers pursue under this code spans direct ELISA testing kits for multi-substance screening (cannabinoids, opiates, PCP, amphetamines, cocaine, benzodiazepines, and other controlled substances), DNA fragment analysis kits, and ISO/IEC 17025–accredited certified reference materials with documented purity and expanded uncertainty specifications. Issuing bodies include state forensic crime labs and public safety agencies, state health and human services departments, county forensic laboratories, and specialized law enforcement divisions. The code is relatively quiet; recent activity centers on a few high-specificity procurements from forensic and toxicology units within larger state and county systems.

Recent opportunities cluster in Texas and Florida. The Texas Department of Public Safety Crime Lab Division posted IFB 40526R0008445A in July 2026 for immunalysis reagent kits (12 line items, due July 23, 2026), while the Texas Health and Human Services Commission (on behalf of the Department of State Health Services) conducted IFB HHS0016902v2 for QIAxcel and QIAamp DNA screening kits with a January 29, 2026 closing. Pinellas County, Florida (in partnership with the Florida Department of Law Enforcement) issued Invitation to Quote 26-0305-ITQ in April 2026 for 131 line items of certified drug reference standards, with federal Coverdell Forensic Sciences Improvement Act Program funding totaling $72,126.85. The Illinois Department of Financial and Professional Regulation issued a sole-source notice of intent in May 2026 for RAMP mosquito-borne virus testing equipment (West Nile and dengue test kits) through ADAPCO as the exclusive authorized distributor. Most procurements run one year with extension options; evaluation generally follows best-value standards rather than lowest price alone. SBE preference applies in Florida; Texas enforces HUB subcontracting plan requirements. Response deadlines are typically tight (often same-day or within two weeks of posting).